✕
Login
Register
Back to News
Morgan Stanley Maintains Overweight on Astera Labs, Raises Price Target to $240
Benzinga Newsdesk
www.benzinga.com
Positive 91.4%
Neg 0%
Neu 0%
Pos 91.4%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment